---
category: news
title: "One Key to Pandemic Retailing: Artificial Intelligence"
excerpt: "Retail is no stranger to artificial intelligence. Nearly a decade ago ... Gilead Sciences won approval for remdesivir as an anti-Covid therapy. With the election looming, House Speaker Nancy Pelosi set a Tuesday deadline to reach a deal on Covid relief."
publishedDateTime: 2020-10-24T04:07:00Z
originalUrl: "https://www.barrons.com/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
webUrl: "https://www.barrons.com/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
ampWebUrl: "https://www.barrons.com/amp/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
cdnAmpWebUrl: "https://www-barrons-com.cdn.ampproject.org/c/s/www.barrons.com/amp/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
type: article

provider:
  name: Barron's
  domain: barrons.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://images.barrons.com/im-248999/social"
    width: 1280
    height: 640
    isCached: true

secured: "qhli5V1wHYdzv7f/DOLD7fi5xdrR81Qwa52cUUuz4DRn3j63Vjsk5csgdcZq6YgCH1gC9EdYvAvFino2Vctc7WGReN0kE1pL25M/olOS/2dAOb5VapoD54HFQhQEwA/E+LzgoNhvwuGk7ExZiQN2z8Aek6LYLa8FRV1sJm3senuD+P6mko4soT341Uc5PkFwQmOdQlj2AUJvenHfJ/+EQ3qifA1vqzudeW/EYZF1OgM3M8AXbmpBdxpcRl6OrhVtbl0o0edw9W+8JWWaPR7PXGrZixDsCbOr9vVIDP4b1KCsXJSTyEOxu51KWZCMOEtKy2zSKlWQwY9D6y4Q99uga/GDb8ro3Ah4jLN1lFguSts=;OrNXt8fqG+X6gPC4yUUUsw=="
---

